Recommendations for Titration and Administration of Oral Semaglutide for the Treatment of Type 2 Diabetes during Ramadan
Background: Injectable glucagon-like peptide-1 receptor agonists (GLP-1RAs) are proven to be well tolerated and efficacious in people with type 2 diabetes mellitus (T2DM) fasting during Ramadan. The first oral GLP-1RA semaglutide, also indicated for the treatment of T2DM, has specific dosing instruc...
Saved in:
| Main Authors: | Mohamed Hassanein, Abdulqawi Almansari, Ebtesam Ba-Essa, Fatheya F. Alawadi, Hussein ElBadawi, Rakesh Kumar Sahay, Rayaz Malik, Rohana Abdul Ghani, Salah Abusnana, Shehla Shaikh, Sueziani Binte Zainudin, Tarik Elhadd, Yousef AL Saleh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Knowledge E
2022-12-01
|
| Series: | Dubai Diabetes and Endocrinology Journal |
| Subjects: | |
| Online Access: | https://www.karger.com/Article/FullText/527475 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preparing muslims with diabetes mellitus for Ramadan fasting in Singapore: a clinical approach and review of current practice
by: Sueziani Binte Zainudin, et al.
Published: (2022-11-01) -
Variability among Physicians in Risk Stratification for People with Diabetes during Ramadan Fasting
by: Bachar Afandi, et al.
Published: (2023-01-01) -
Editorial: The model of Ramadan diurnal intermittent fasting: unraveling the health implications, volume III
by: MoezAlIslam Ezzat Faris, et al.
Published: (2025-04-01) -
The impact of healthcare provision on immigrant pregnancy behaviors: the case of Ramadan fasting in Germany
by: Paul Witte, et al.
Published: (2025-01-01) -
Incidence of hypoglycemia among patients with type 2 diabetes who fasted during Ramadan
by: Bayar Ahmed Qasim, et al.
Published: (2024-03-01)